BPC-157 10mg

Product Overview

BPC-157 10mg is a synthetic peptide fragment derived from a protective protein sequence originally identified in gastric juice. The peptide consists of a 15-amino-acid sequence and is frequently examined in laboratory environments investigating peptide signaling pathways, cellular regulatory mechanisms, and molecular stability.

Peptides are short chains of amino acids that function as signaling molecules within biological systems. Researchers commonly study peptide fragments in controlled experimental environments to better understand receptor interaction dynamics, intracellular signaling pathways, and peptide-mediated molecular communication.

BPC-157 10mg has become a molecule of interest in peptide research due to its stability characteristics and its role in experimental investigations involving peptide signaling mechanisms.

Chemical Information

Peptide Name: BPC-157 10mg
Quantity: 10mg
Sequence Length: 15 amino acids
Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: ~1419.5 g/mol
Purity: ≥99%
Appearance: Lyophilized white powder

Analytical Verification

Each batch of BPC-157 10mg undergoes analytical verification to confirm compound identity and purity. Analytical procedures commonly include high-performance liquid chromatography (HPLC) and additional analytical techniques used to evaluate peptide composition and structural integrity.

Verification procedures evaluate:

• peptide purity profile
• chromatographic retention time
• batch consistency
• molecular identity confirmation

Analytical data corresponding to each batch is documented through a Certificate of Analysis (COA).

Certificate of Analysis

A Certificate of Analysis provides documentation associated with a specific production lot. These documents typically contain analytical data confirming compound purity and laboratory testing methodology.

COA documentation commonly includes:

• batch identification number
• purity percentage
• chromatographic testing results
• analytical method
• laboratory verification data

Researchers reference COA documentation to maintain traceability and consistency within experimental workflows.

Peptide Synthesis

BPC-157 10mg is produced using solid-phase peptide synthesis (SPPS), a process widely used for assembling peptide sequences through sequential amino acid coupling.

The synthesis process typically includes:

1. sequential amino acid assembly

2. purification using chromatographic separation

3. analytical confirmation of molecular identity

4. lyophilization to maintain compound stability

Following purification, the compound is freeze-dried to preserve structural integrity during storage and transportation.

Storage Conditions

Lyophilized peptides should be stored under controlled conditions to maintain stability.

Recommended handling considerations include:

• storing in a cool dry environment
• minimizing exposure to moisture and heat
• avoiding repeated freeze-thaw cycles after reconstitution

Proper storage helps maintain compound integrity during laboratory research.

Available Sizes

BPC-157 – 5mg
BPC-157 – 10mg

Each vial is labeled with batch identification to support traceability for laboratory research applications.

Related Peptide Compounds

Researchers investigating peptide signaling pathways often examine related peptide compounds including:

BPC+TB – 10mg

KLOW – 80mg

GLOW – 70mg

These peptides are commonly studied in laboratory research environments investigating peptide interaction and regulatory signaling pathways.

References

Scientific literature describing peptide signaling mechanisms and experimental peptide research is available through peer-reviewed research databases.

PubMed

Disclaimer

This product is supplied for laboratory research use only.
Not intended for human or veterinary use.

Products distributed by Aevitas Research are intended exclusively for laboratory research purposes and must be handled by qualified professionals in controlled research environments.